Literature DB >> 23147205

High yield purification of JNK1β1 and activation by in vitro reconstitution of the MEKK1→MKK4→JNK MAPK phosphorylation cascade.

Gavin R Owen1, Ikechukwu Achilonu, Heini W Dirr.   

Abstract

The c-Jun N-terminal kinase (JNK) pathway forms part of the mitogen-activated protein kinase (MAPK) signaling pathways comprising a sequential three-tiered kinase cascade. Here, an upstream MAP3K (MEKK1) phosphorylates and activates a MAP2K (MKK4 and MKK7), which in turn phosphorylates and activates the MAPK, JNK. The C-terminal kinase domain of MEKK1 (MEKK-C) is constitutively active, while MKK4/7 and JNK are both activated by dual phosphorylation of S/Y, and T/Y residues within their activation loops, respectively. While improvements in the purification of large quantities of active JNKs have recently been made, inadequacies in their yield, purity, and the efficiency of their phosphorylation still exist. We describe a novel and robust method that further improves upon the purification of large yields of highly pure, phosphorylated JNK1β1, which is most suitable for biochemical and biophysical characterization. Codon harmonization of the JNK1β1 gene was used as a precautionary measure toward increasing the soluble overexpression of the kinase. While JNK1β1 and its substrate ATF2 were both purified to >99% purity as GST fusion proteins using GSH-agarose affinity chromatography and each cleaved from GST using thrombin, constitutively-active MEKK-C and inactive MKK4 were separately expressed in E. coli as thioredoxin-His(6)-tagged proteins and purified using urea refolding and Ni(2+)-IMAC, respectively. Activation of JNK1β1 was then achieved by successfully reconstituting the JNK MAPK activation cascade in vitro; MEKK-C was used to activate MKK4, which in turn was used to efficiently phosphorylate and activate large quantities of JNK1β1. Activated JNK1β1 was thereafter able to phosphorylate ATF2 with high catalytic efficiency.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23147205     DOI: 10.1016/j.pep.2012.10.010

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  6 in total

1.  miR-92a inhibits vascular smooth muscle cell apoptosis: role of the MKK4-JNK pathway.

Authors:  Lan Zhang; Mi Zhou; Yingjie Wang; Weibin Huang; Gangjian Qin; Neal L Weintraub; Yaoliang Tang
Journal:  Apoptosis       Date:  2014-06       Impact factor: 4.677

2.  Overexpression of C-terminal fragment of glutamate receptor 6 prevents neuronal injury in kainate-induced seizure via disassembly of GluR6-PSD-95-MLK3 signaling module.

Authors:  Jie Mou; Xiaomei Liu; Dongsheng Pei
Journal:  Neural Regen Res       Date:  2014-12-01       Impact factor: 5.135

3.  A conserved motif in JNK/p38-specific MAPK phosphatases as a determinant for JNK1 recognition and inactivation.

Authors:  Xin Liu; Chen-Song Zhang; Chang Lu; Sheng-Cai Lin; Jia-Wei Wu; Zhi-Xin Wang
Journal:  Nat Commun       Date:  2016-03-18       Impact factor: 14.919

4.  Codon Harmonization of a Kir3.1-KirBac1.3 Chimera for Structural Study Optimization.

Authors:  Evan van Aalst; Maryam Yekefallah; Anil K Mehta; Isaac Eason; Benjamin Wylie
Journal:  Biomolecules       Date:  2020-03-10

5.  A histone deacetylase 7-derived peptide promotes vascular regeneration via facilitating 14-3-3γ phosphorylation.

Authors:  Junyao Yang; Ana Moraga; Jing Xu; Yue Zhao; Peiyi Luo; Ka Hou Lao; Andriana Margariti; Qiang Zhao; Wei Ding; Gang Wang; Min Zhang; Lei Zheng; Zhongyi Zhang; Yanhua Hu; Wen Wang; Lisong Shen; Alberto Smith; Ajay M Shah; Qian Wang; Lingfang Zeng
Journal:  Stem Cells       Date:  2020-01-29       Impact factor: 6.277

Review 6.  COPB2: a transport protein with multifaceted roles in cancer development and progression.

Authors:  Y Feng; X Lei; L Zhang; H Wan; H Pan; J Wu; M Zou; L Zhu; Y Mi
Journal:  Clin Transl Oncol       Date:  2021-06-08       Impact factor: 3.405

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.